ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase 2, open-label study of CUDC-907 with and without rituximab in patients with relapsed/refractory MYC-altered diffuse large B-cell lymphoma.
Journal of Clinical Oncology
◽
10.1200/jco.2016.34.15_suppl.tps7579
◽
2016
◽
Vol 34
(15_suppl)
◽
pp. TPS7579-TPS7579
Author(s):
Daniel Jeffrey Landsburg
◽
Kevin Kelly
◽
Jaye Viner
◽
Jing Wang
◽
Lucy Gong
◽
...
Keyword(s):
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Phase 2
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Related Documents
Cited By
References
A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-16-2818
◽
2017
◽
Vol 23
(15)
◽
pp. 4127-4137
◽
Cited By ~ 64
Author(s):
Myron S. Czuczman
◽
Marek Trněný
◽
Andrew Davies
◽
Simon Rule
◽
Kim M. Linton
◽
...
Keyword(s):
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Phase 2
◽
Efficacy And Safety
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Faculty of 1000 evaluation for Phase II Open Label Study of the oral VEGF-Receptor inhibitor PTK787/ZK222584 (Vatalanib) in Adult Patients with Refractory or Relapsed Diffuse Large B Cell Lymphoma.
F1000 - Post-publication peer review of the biomedical literature
◽
10.3410/f.717995403.793474246
◽
2013
◽
Author(s):
Nicolas Mounier
Keyword(s):
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Vegf Receptor
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Large B Cell Lymphoma
◽
Large B Cell
◽
Receptor Inhibitor
Download Full-text
Outcomes of Patients (Pts) in ZUMA-9, a Multicenter, Open-Label Study of Axicabtagene Ciloleucel (Axi-Cel) in Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL) for Expanded Access (EA) and Commercial out-of-Specification (OOS) Product
Transplantation and Cellular Therapy
◽
10.1016/s2666-6367(21)00524-8
◽
2021
◽
Vol 27
(3)
◽
pp. S408
Author(s):
Caron A. Jacobson
◽
Frederick L. Locke
◽
David B. Miklos
◽
Julie M. Vose
◽
Yi Lin
◽
...
Keyword(s):
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Expanded Access
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial
The Lancet Haematology
◽
10.1016/s2352-3026(20)30120-4
◽
2020
◽
Vol 7
(7)
◽
pp. e511-e522
◽
Cited By ~ 15
Author(s):
Nagesh Kalakonda
◽
Marie Maerevoet
◽
Federica Cavallo
◽
George Follows
◽
Andre Goy
◽
...
Keyword(s):
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Phase 2
◽
Open Label
◽
Phase 2 Trial
◽
Large B Cell Lymphoma
◽
Open Label Phase
◽
Large B Cell
Download Full-text
A phase I, open-label study of GSK2816126, an enhancer of zeste homolog 2 (EZH2) inhibitor, in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), transformed follicular lymphoma (tFL), other non-Hodgkin’s lymphomas (NHL), multiple myeloma (MM) and solid tumor.
Journal of Clinical Oncology
◽
10.1200/jco.2016.34.15_suppl.tps2595
◽
2016
◽
Vol 34
(15_suppl)
◽
pp. TPS2595-TPS2595
◽
Cited By ~ 6
Author(s):
Timothy Anthony Yap
◽
Peter W. M. Johnson
◽
Jane Winter
◽
John Leonard
◽
Lisa Giulino-Roth
◽
...
Keyword(s):
Multiple Myeloma
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Large B Cell Lymphoma
◽
Hodgkin's Lymphomas
◽
Transformed Follicular Lymphoma
◽
Large B Cell
Download Full-text
Phase II open label study of the oral vascular endothelial growth factor-receptor inhibitor PTK787/ZK222584 (vatalanib) in adult patients with refractory or relapsed diffuse large B-cell lymphoma
Leukemia & Lymphoma
◽
10.3109/10428194.2013.784969
◽
2013
◽
Vol 54
(12)
◽
pp. 2627-2630
◽
Cited By ~ 5
Author(s):
Danielle Brander
◽
David Rizzieri
◽
Jon Gockerman
◽
Louis Diehl
◽
Thomas Charles Shea
◽
...
Keyword(s):
Cell Lymphoma
◽
Growth Factor Receptor
◽
B Cell Lymphoma
◽
Vascular Endothelial
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Large B Cell Lymphoma
◽
Endothelial Growth Factor
◽
Large B Cell
Download Full-text
Faculty Opinions recommendation of Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718389157.793521335
◽
2016
◽
Author(s):
Won Seog Kim
Keyword(s):
Elderly Patients
◽
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Phase 2
◽
Open Label
◽
Multicentre Phase
◽
Phase 2 Trial
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial
The Lancet Oncology
◽
10.1016/s1470-2045(14)70191-3
◽
2014
◽
Vol 15
(7)
◽
pp. 730-737
◽
Cited By ~ 122
Author(s):
Umberto Vitolo
◽
Annalisa Chiappella
◽
Silvia Franceschetti
◽
Angelo Michele Carella
◽
Ileana Baldi
◽
...
Keyword(s):
Elderly Patients
◽
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Phase 2
◽
Open Label
◽
Multicentre Phase
◽
Phase 2 Trial
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial
The Lancet Oncology
◽
10.1016/s1470-2045(21)00139-x
◽
2021
◽
Author(s):
Paolo F Caimi
◽
Weiyun Ai
◽
Juan Pablo Alderuccio
◽
Kirit M Ardeshna
◽
Mehdi Hamadani
◽
...
Keyword(s):
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Phase 2
◽
Open Label
◽
Phase 2 Trial
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
16 / Axicabtagene Ciloleucel in Patients With Refractory Large B Cell Lymphoma: Outcomes by Prior Lines of Therapy in the Pivotal Phase 2 Study, ZUMA-1
10.26226/morressier.5b3b802db1b87b000eceda9c
◽
2018
◽
Author(s):
Locke Frederick L.
Keyword(s):
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Phase 2
◽
Pivotal Phase
◽
Large B Cell Lymphoma
◽
Phase 2 Study
◽
Large B Cell
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close